Beaumont Financial Advisors »

Arrowhead Pharmaceuticals shares owned by Beaumont Financial Advisors

Quarter-by-quarter ownership of Arrowhead Pharmaceuticals (ARWR) shares owned by Beaumont Financial Advisors from 13F filings

Historical chart of Beaumont Financial Advisors investment in Arrowhead Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Arrowhead Pharmaceuticals held by Beaumont Financial Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arrowhead Pharmaceuticals by Beaumont Financial Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $291k 10k 28.60
2023-12-31 $311k 10k 30.60
2023-09-30 $285k 11k 26.87
2023-06-30 $379k 11k 35.66
2023-03-31 $269k 11k 25.40
2022-12-31 $427k 11k 40.56

More positions owned by Beaumont Financial Advisors

Microsoft Corp Stock (MSFT)
Apple Stock (AAPL)
Ishares Core S&p 500 Etf Etf (IVV)
Jpmorgan Active Growth Etf Etf (JGRO)
Alphabet Inc Cap Stk Cl A Stock (GOOGL)
Ishares Core S&p Mid-cap Etf Etf (IJH)
Amazon Stock (AMZN)
Ishares Global 100 Etf Etf (IOO)
Jpmorgan U.s. Quality Factor Etf Us Quality Factor Fund Etf (JQUA)
Vaneck Morningstar Wide Moat Etf Etf (MOAT)
Ishares S&p Small-cap 600 Growth Etf Etf (IJT)
Blackstone Private Credit Fund Shs Cl I Stock
Lowes Cos Stock (LOW)
Berkshire Hathaway Inc Del Cl B Stock (BRK.B)
Fidelity Fundamental Large Cap Core Etf Etf (FFLC)

View all positions for Beaumont Financial Advisors

Top funds holding Arrowhead Pharmaceuticals

BlackRock
Vanguard Group
FMR
Artal Group
Geode Capital Management
Jpmorgan Chase & Co
T. Rowe Price Investment Management
Credit Suisse
Northern Trust
Rokos Capital Management
Pictet Asset Management Holding SA
Morgan Stanley
venBio Select Advisor
Bank of New York Mellon
Goldman Sachs Group

View all funds holding Arrowhead Pharmaceuticals